Literature DB >> 33353538

Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study.

Akira Iwanami1, Kazuhiko Saito2, Masakazu Fujiwara3, Daiki Okutsu4, Hironobu Ichikawa5.   

Abstract

Entities:  

Year:  2020        PMID： 33353538      PMCID： PMC7756943          DOI： 10.1186/s12888-020-02965-7

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN： 1471-244X            Impact factor:   3.630


× No keyword cloud information.
  1 in total

1.  Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study.

Authors:  Akira Iwanami; Kazuhiko Saito; Masakazu Fujiwara; Daiki Okutsu; Hironobu Ichikawa
Journal:  BMC Psychiatry       Date:  2020-10-02       Impact factor: 3.630
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.